Global Peripheral Arterial Disease (PAD) Therapeutics Market Insights, Forecast to 2031

Report ID: 1666989 | Published Date: Oct 2024 | No. of Page: 113 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Anti-Platelet Drugs
        1.2.3 Dual Antiplatelet Therapy Drugs
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Perspective (2017-2028)
    2.2 Peripheral Arterial Disease (PAD) Therapeutics Growth Trends by Region
        2.2.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Peripheral Arterial Disease (PAD) Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Peripheral Arterial Disease (PAD) Therapeutics Market Dynamics
        2.3.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Trends
        2.3.2 Peripheral Arterial Disease (PAD) Therapeutics Market Drivers
        2.3.3 Peripheral Arterial Disease (PAD) Therapeutics Market Challenges
        2.3.4 Peripheral Arterial Disease (PAD) Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Revenue
        3.1.1 Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Peripheral Arterial Disease (PAD) Therapeutics Revenue
    3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Ratio
        3.4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2021
    3.5 Peripheral Arterial Disease (PAD) Therapeutics Key Players Head office and Area Served
    3.6 Key Players Peripheral Arterial Disease (PAD) Therapeutics Product Solution and Service
    3.7 Date of Enter into Peripheral Arterial Disease (PAD) Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Arterial Disease (PAD) Therapeutics Breakdown Data by Type
    4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Type (2023-2028)
5 Peripheral Arterial Disease (PAD) Therapeutics Breakdown Data by Application
    5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2017-2028)
    6.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
        6.2.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2017-2028)
    6.3 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
        6.3.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2017-2028)
    6.4 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
        6.4.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (2017-2028)
    7.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
        7.2.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
        7.3.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
        7.4.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2017-2028)
    9.2 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
        9.2.1 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
        9.3.1 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
        9.4.1 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AstraZeneca Plc. (UK)
        11.1.1 AstraZeneca Plc. (UK) Company Details
        11.1.2 AstraZeneca Plc. (UK) Business Overview
        11.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.1.4 AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.1.5 AstraZeneca Plc. (UK) Recent Developments
    11.2 Bayer HealthCare Pharmaceuticals (Germany)
        11.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details
        11.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
        11.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.2.4 Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
    11.3 Bristol-Myers Squibb Company (US)
        11.3.1 Bristol-Myers Squibb Company (US) Company Details
        11.3.2 Bristol-Myers Squibb Company (US) Business Overview
        11.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.3.4 Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.3.5 Bristol-Myers Squibb Company (US) Recent Developments
    11.4 Merck & Co., Inc. (US)
        11.4.1 Merck & Co., Inc. (US) Company Details
        11.4.2 Merck & Co., Inc. (US) Business Overview
        11.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.4.4 Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.4.5 Merck & Co., Inc. (US) Recent Developments
    11.5 Proteon Therapeutics, Inc. (US)
        11.5.1 Proteon Therapeutics, Inc. (US) Company Details
        11.5.2 Proteon Therapeutics, Inc. (US) Business Overview
        11.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.5.4 Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.5.5 Proteon Therapeutics, Inc. (US) Recent Developments
    11.6 Sanofi S.A. (France)
        11.6.1 Sanofi S.A. (France) Company Details
        11.6.2 Sanofi S.A. (France) Business Overview
        11.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.6.4 Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.6.5 Sanofi S.A. (France) Recent Developments
    11.7 Symic Bio, Inc. (US)
        11.7.1 Symic Bio, Inc. (US) Company Details
        11.7.2 Symic Bio, Inc. (US) Business Overview
        11.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.7.4 Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.7.5 Symic Bio, Inc. (US) Recent Developments
    11.8 TheraVasc Inc. (US)
        11.8.1 TheraVasc Inc. (US) Company Details
        11.8.2 TheraVasc Inc. (US) Business Overview
        11.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.8.4 TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.8.5 TheraVasc Inc. (US) Recent Developments
    11.9 AnGes MG, Inc. (Japan)
        11.9.1 AnGes MG, Inc. (Japan) Company Details
        11.9.2 AnGes MG, Inc. (Japan) Business Overview
        11.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.9.4 AnGes MG, Inc. (Japan) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.9.5 AnGes MG, Inc. (Japan) Recent Developments
    11.10 Athersys, Inc. (US)
        11.10.1 Athersys, Inc. (US) Company Details
        11.10.2 Athersys, Inc. (US) Business Overview
        11.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.10.4 Athersys, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.10.5 Athersys, Inc. (US) Recent Developments
    11.11 Betagenon AB (Sweden)
        11.11.1 Betagenon AB (Sweden) Company Details
        11.11.2 Betagenon AB (Sweden) Business Overview
        11.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.11.4 Betagenon AB (Sweden) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.11.5 Betagenon AB (Sweden) Recent Developments
    11.12 miRagen Therapeutics, Inc. (US)
        11.12.1 miRagen Therapeutics, Inc. (US) Company Details
        11.12.2 miRagen Therapeutics, Inc. (US) Business Overview
        11.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.12.4 miRagen Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.12.5 miRagen Therapeutics, Inc. (US) Recent Developments
    11.13 Multi Gene Vascular Systems Ltd (Israel)
        11.13.1 Multi Gene Vascular Systems Ltd (Israel) Company Details
        11.13.2 Multi Gene Vascular Systems Ltd (Israel) Business Overview
        11.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.13.4 Multi Gene Vascular Systems Ltd (Israel) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.13.5 Multi Gene Vascular Systems Ltd (Israel) Recent Developments
    11.14 ViroMed Co. Ltd. (Korea)
        11.14.1 ViroMed Co. Ltd. (Korea) Company Details
        11.14.2 ViroMed Co. Ltd. (Korea) Business Overview
        11.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Introduction
        11.14.4 ViroMed Co. Ltd. (Korea) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
        11.14.5 ViroMed Co. Ltd. (Korea) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Anti-Platelet Drugs
    Table 3. Key Players of Dual Antiplatelet Therapy Drugs
    Table 4. Key Players of Others
    Table 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Region (2023-2028)
    Table 11. Peripheral Arterial Disease (PAD) Therapeutics Market Trends
    Table 12. Peripheral Arterial Disease (PAD) Therapeutics Market Drivers
    Table 13. Peripheral Arterial Disease (PAD) Therapeutics Market Challenges
    Table 14. Peripheral Arterial Disease (PAD) Therapeutics Market Restraints
    Table 15. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Players (2017-2022)
    Table 17. Global Top Peripheral Arterial Disease (PAD) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2021)
    Table 18. Ranking of Global Top Peripheral Arterial Disease (PAD) Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Peripheral Arterial Disease (PAD) Therapeutics Product Solution and Service
    Table 22. Date of Enter into Peripheral Arterial Disease (PAD) Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Application (2017-2022)
    Table 30. Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Application (2023-2028)
    Table 32. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 62. AstraZeneca Plc. (UK) Company Details
    Table 63. AstraZeneca Plc. (UK) Business Overview
    Table 64. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 65. AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. AstraZeneca Plc. (UK) Recent Developments
    Table 67. Bayer HealthCare Pharmaceuticals (Germany) Company Details
    Table 68. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
    Table 69. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 70. Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
    Table 72. Bristol-Myers Squibb Company (US) Company Details
    Table 73. Bristol-Myers Squibb Company (US) Business Overview
    Table 74. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 75. Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Bristol-Myers Squibb Company (US) Recent Developments
    Table 77. Merck & Co., Inc. (US) Company Details
    Table 78. Merck & Co., Inc. (US) Business Overview
    Table 79. Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 80. Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Merck & Co., Inc. (US) Recent Developments
    Table 82. Proteon Therapeutics, Inc. (US) Company Details
    Table 83. Proteon Therapeutics, Inc. (US) Business Overview
    Table 84. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 85. Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Proteon Therapeutics, Inc. (US) Recent Developments
    Table 87. Sanofi S.A. (France) Company Details
    Table 88. Sanofi S.A. (France) Business Overview
    Table 89. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 90. Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. Sanofi S.A. (France) Recent Developments
    Table 92. Symic Bio, Inc. (US) Company Details
    Table 93. Symic Bio, Inc. (US) Business Overview
    Table 94. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 95. Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 96. Symic Bio, Inc. (US) Recent Developments
    Table 97. TheraVasc Inc. (US) Company Details
    Table 98. TheraVasc Inc. (US) Business Overview
    Table 99. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 100. TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 101. TheraVasc Inc. (US) Recent Developments
    Table 102. AnGes MG, Inc. (Japan) Company Details
    Table 103. AnGes MG, Inc. (Japan) Business Overview
    Table 104. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 105. AnGes MG, Inc. (Japan) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 106. AnGes MG, Inc. (Japan) Recent Developments
    Table 107. Athersys, Inc. (US) Company Details
    Table 108. Athersys, Inc. (US) Business Overview
    Table 109. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 110. Athersys, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 111. Athersys, Inc. (US) Recent Developments
    Table 112. Betagenon AB (Sweden) Company Details
    Table 113. Betagenon AB (Sweden) Business Overview
    Table 114. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 115. Betagenon AB (Sweden) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 116. Betagenon AB (Sweden) Recent Developments
    Table 117. miRagen Therapeutics, Inc. (US) Company Details
    Table 118. miRagen Therapeutics, Inc. (US) Business Overview
    Table 119. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 120. miRagen Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 121. miRagen Therapeutics, Inc. (US) Recent Developments
    Table 122. Multi Gene Vascular Systems Ltd (Israel) Company Details
    Table 123. Multi Gene Vascular Systems Ltd (Israel) Business Overview
    Table 124. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 125. Multi Gene Vascular Systems Ltd (Israel) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 126. Multi Gene Vascular Systems Ltd (Israel) Recent Developments
    Table 127. ViroMed Co. Ltd. (Korea) Company Details
    Table 128. ViroMed Co. Ltd. (Korea) Business Overview
    Table 129. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product
    Table 130. ViroMed Co. Ltd. (Korea) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022) & (US$ Million)
    Table 131. ViroMed Co. Ltd. (Korea) Recent Developments
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Anti-Platelet Drugs Features
    Figure 3. Dual Antiplatelet Therapy Drugs Features
    Figure 4. Others Features
    Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application: 2021 VS 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Peripheral Arterial Disease (PAD) Therapeutics Report Years Considered
    Figure 10. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2021
    Figure 16. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 18. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 19. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Country (2017-2028)
    Figure 20. United States Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Country (2017-2028)
    Figure 26. Germany Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Region (2017-2028)
    Figure 36. China Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Country (2017-2028)
    Figure 46. Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Country (2017-2028)
    Figure 52. Turkey Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. AstraZeneca Plc. (UK) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 56. Bayer HealthCare Pharmaceuticals (Germany) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 57. Bristol-Myers Squibb Company (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 58. Merck & Co., Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 59. Proteon Therapeutics, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 60. Sanofi S.A. (France) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 61. Symic Bio, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 62. TheraVasc Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 63. AnGes MG, Inc. (Japan) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 64. Athersys, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 65. Betagenon AB (Sweden) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 66. miRagen Therapeutics, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 67. Multi Gene Vascular Systems Ltd (Israel) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 68. ViroMed Co. Ltd. (Korea) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
AnGes MG, Inc. (Japan)
Athersys, Inc. (US)
Betagenon AB (Sweden)
miRagen Therapeutics, Inc. (US)
Multi Gene Vascular Systems Ltd (Israel)
ViroMed Co. Ltd. (Korea)
Frequently Asked Questions
Peripheral Arterial Disease (PAD) Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Peripheral Arterial Disease (PAD) Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Peripheral Arterial Disease (PAD) Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Perms and Relaxants

Perms and Relaxants market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Personal Computers

Personal Computers market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More